Resmed Inc Stock Analysis

RMD Stock  USD 217.89  4.07  1.90%   
ResMed Inc is undervalued with Real Value of 239.83 and Hype Value of 217.89. The main objective of ResMed stock analysis is to determine its intrinsic value, which is an estimate of what ResMed Inc is worth, separate from its market price. There are two main types of ResMed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect ResMed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of ResMed's stock to identify patterns and trends that may indicate its future price movements.
The ResMed stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ResMed is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. ResMed Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ResMed's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

ResMed Stock Analysis Notes

About 60.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.75. ResMed Inc recorded earning per share (EPS) of 6.5. The entity last dividend was issued on the 8th of May 2024. The firm had 2:1 split on the 31st of August 2010. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 8160 people. To find out more about ResMed Inc contact BE MBA at 858-836-5000 or learn more at https://www.resmed.com.

ResMed Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ResMed's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ResMed Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
About 60.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Haemonetics Q4 Earnings Top Estimates, Margins Expand

ResMed Inc Upcoming and Recent Events

Earnings reports are used by ResMed to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ResMed previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of April 2024
Upcoming Quarterly Report
View
1st of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
1st of August 2024
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

ResMed Thematic Classifications

In addition to having ResMed stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Medical Equipment Idea
Medical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

ResMed Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 31.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

ResMed Profitablity

ResMed's profitability indicators refer to fundamental financial ratios that showcase ResMed's ability to generate income relative to its revenue or operating costs. If, let's say, ResMed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, ResMed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of ResMed's profitability requires more research than a typical breakdown of ResMed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.21 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.31 %, which entails that for every 100 dollars of revenue, it generated $0.31 of operating income.

Technical Drivers

As of the 13th of May 2024, ResMed holds the Risk Adjusted Performance of 0.0713, coefficient of variation of 973.11, and Semi Deviation of 1.69. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ResMed, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for nineteen technical drivers for ResMed Inc, which can be compared to its competitors. Please check ResMed Inc information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if ResMed Inc is priced some-what accurately, providing market reflects its current price of 217.89 per share. Given that ResMed has jensen alpha of 0.189, we recommend you to check out ResMed Inc's recent market performance to make sure the company can sustain itself at a future point.

ResMed Inc Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ResMed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ResMed Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

ResMed Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ResMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on ResMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ResMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ResMed Predictive Daily Indicators

ResMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ResMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ResMed Forecast Models

ResMed's time-series forecasting models are one of many ResMed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ResMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About ResMed Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ResMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ResMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ResMed. By using and applying ResMed Stock analysis, traders can create a robust methodology for identifying ResMed entry and exit points for their positions.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 8160 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ResMed to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.